Diagnostic and prognostic role of thrombospondin‐4 levels in pre‐eclampsia: Association with onset type, severity, and perinatal outcome
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70456 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Ruken Dayanan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Pre-Eclampsia, Thrombospondins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the diagnostic and prognostic significance of maternal serum thrombospondin‐4 (TSP‐4) levels in pre‐eclampsia (PE), including comparisons between early‐ and late‐onset disease and between mild and severe cases, and to examine associations with adverse perinatal outcomes.
Methods
A prospective study was conducted including 45 pregnant women with PE (stratified by onset type and severity) and 45 gestational age‐matched normotensive controls. Serum TSP‐4 concentrations were measured by enzyme‐linked immunosorbent assay (ELISA). Group differences were analyzed, and receiver operating characteristic (ROC) curves were generated to assess the diagnostic performance of TSP‐4 for PE and its prognostic value for adverse outcomes.
Results
Maternal TSP‐4 levels were significantly elevated in PE patients compared to controls. Using a cutoff value of >6.42 ng/mL, TSP‐4 levels could distinguish PE cases with a sensitivity of 86%, a specificity of 73%, and an area under the curve (AUC) of 0.891 ( P = 0.001). At a cutoff of >7.22 ng/mL, it was significantly associated with composite adverse neonatal outcomes, with a sensitivity of 76%, a specificity of 74%, and an AUC of 0.742 ( P = 0.001). At a cutoff of >9.72 ng/mL, it was significantly associated with severe PE, with a sensitivity of 70%, a specificity of 74%, and an AUC of 0.792 ( P = 0.001).
Conclusion
Maternal serum TSP‐4 is a promising biomarker in PE, reflecting disease presence and severity. Elevated TSP‐4 levels, particularly in early‐onset and severe cases, underscore its pathophysiological role and potential utility for clinical diagnosis and risk stratification in affected pregnancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.
ORCID-Profile: Ruken Dayanan, Dilara Duygulu Bulan, Kadriye Yakut Yucel
Zitieren
APA
Dayanan, R., Bulan, D. D., & Yucel, K. Y. (2025). Diagnostic and prognostic role of thrombospondin‐4 levels in pre‐eclampsia: Association with onset type, severity, and perinatal outcome. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70456
Vancouver
Dayanan R, Bulan DD, Yucel KY. Diagnostic and prognostic role of thrombospondin‐4 levels in pre‐eclampsia: Association with onset type, severity, and perinatal outcome. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70456
BibTeX
@article{Dayanan2025,
author = {Dayanan, Ruken and Bulan, Dilara Duygulu and Yucel, Kadriye Yakut},
title = {Diagnostic and prognostic role of thrombospondin‐4 levels in pre‐eclampsia: Association with onset type, severity, and perinatal outcome},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70456}
}
EUVIMED